Table: Fuso Pharmaceutical -2024/25 parent results

Fuso Pharmaceutical Industries

28/05/2025 01:00

May 28 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended       Year to       NEXT   
               Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                  LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales           60.56            55.41          61.50        30.60    
                (+9.3 pct)      (+8.6 pct)     (+1.5 pct)    (+2.9 pct) 
  Operating        4.13             1.96           3.40         1.60    
               (+110.3 pct)     (-11.0 pct)    (-17.7 pct)  (-34.3 pct) 
  Recurring        3.78             1.87           3.30         1.60    
               (+102.4 pct)     (-15.7 pct)    (-12.7 pct)  (-25.4 pct) 
  Net           loss 3.29           1.38           2.30         1.10    
                                (-14.2 pct)                 (-28.4 pct) 
  EPS        loss 384.95 yen    159.98 yen     269.24 yen    128.77 yen 
  Ann Div       82.00 yen        70.00 yen      90.00 yen               
  -Q2 Div       40.00 yen        35.00 yen      45.00 yen               
  -Q4 Div       42.00 yen        35.00 yen      45.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T